Bevacizumab in the Treatment of Glioblastoma: Is there an Optimal Dose or Schedule?
Book:
Controversies in Neuro-Oncology
Page:
54-58
Author(s):
L. Kamsheh, P. Kumthekar and J. J. Raizer
Is Bevacizumab Administration Safe When Combined with Therapeutic Anticoagulation in Patients with High-grade Glioma?
Book:
Controversies in Neuro-Oncology
Page:
51-53
Author(s):
Lisa R. Rogers
Bevacizumab Toxicity in Glioblastoma
Book:
Controversies in Neuro-Oncology
Page:
46-50
Author(s):
Dawit Aregawi and David Schiff
Bevacizumab and Malignant Glioma: Is there a Role for Upfront Therapy?
Book:
Controversies in Neuro-Oncology
Page:
40-45
Author(s):
Jing Wu and Mark R. Gilbert
Bevacizumab Plus Radiotherapy in Malignant Gliomas: Is there a Role?
Book:
Controversies in Neuro-Oncology
Page:
33-39
Author(s):
Minesh Mehta, Disha Patel and Arnab Chakravarti
An Update on the Role of Anti-Angiogenic Therapy for Newly Diagnosed Glioblastoma
Book:
Controversies in Neuro-Oncology
Page:
28-32
Author(s):
David A. Reardon, Sith Sathornsumetee and James V. Vredenburgh
Bevacizumab Failure in Patients with Recurrent Malignant Glioma
Book:
Controversies in Neuro-Oncology
Page:
24-27
Author(s):
Andrew D. Norden
Bevacizumab with Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
Book:
Controversies in Neuro-Oncology
Page:
19-23
Author(s):
Fabio M. Iwamoto and Philip H. Gutin
Avastin and Malignant Gliomas: Is there a Role?
Book:
Controversies in Neuro-Oncology
Page:
12-18
Author(s):
Teri N. Kreisl
Avastin for Recurrent Malignant Gliomas
Book:
Controversies in Neuro-Oncology
Page:
7-11
Author(s):
Annick Desjardins and James J. Vredenburgh